Tilos Therapeutics Overview

  • Founded
  • 2016
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $773M
Latest Deal Amount

Tilos Therapeutics General Information

Description

Developer of antibody therapeutics designed to treat cancer, fibrosis and related disorders. The company's antibody therapeutics harnesses the power of the immune system to develop new therapies that target key immunological pathways with a primary focus on regulatory T cells and regulation of effector cells, enabling patients to start treatment more quickly, resulting in a better medical outcome.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Parent Company
Primary Office
  • 65 Hayden Avenue
  • Lexington, MA 02421
  • United States
+1 (781) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Tilos Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 01-Jun-2019 $773M 00.00 00000 Completed Startup
2. Seed Round 21-Sep-2017 00.000 00.00 00.000 Completed Startup
1. Seed Round 30-Aug-2016 $750K $750K 00.000 Completed Startup
To view Tilos Therapeutics’s complete valuation and funding history, request access »

Tilos Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 0,000,000 00.000000 00 00 00 00 00 00.000
To view Tilos Therapeutics’s complete cap table history, request access »

Tilos Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of antibody therapeutics designed to treat cancer, fibrosis and related disorders. The company's antibody ther
Biotechnology
Lexington, MA
00.00
0000 0000-00-00
000000&0 00.00

0000 000

re magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip
0000000000000
Santa Monica, CA
000 As of 0000
00000
000 0000-00-00
000000&0 00000

0000 000

nsectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut eni
0000000000000
Helsinki, Finland
00 As of 0000
000.00
000 0000-00-00
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Tilos Therapeutics Competitors (103)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Kite Pharma Formerly VC-backed Santa Monica, CA 000 00000 000000&0 00000
0000 0000000000000 Venture Capital-Backed Helsinki, Finland 00 000.00 0000000000 0 000.00
0000000 Venture Capital-Backed Cambridge, MA 000 00000000000 000
00 0000000 Venture Capital-Backed Copenhagen, Denmark 00 00000 00000000000 00000
0000 00000000000 Venture Capital-Backed Cambridge, MA 00 00000 00000000000 00000
You’re viewing 5 of 103 competitors. Get the full list »

Tilos Therapeutics Executive Team (3)

Name Title Board Seat Contact Info
Jessie English Ph.D Chief Scientific Officer
You’re viewing 1 of 3 executive team members. Get the full list »

Tilos Therapeutics Board Members (8)

Name Representing Role Since
Detlev Biniszkiewicz Ph.D Self Board Member 000 0000
James Kasuboski Ph.D Self Board Member 000 0000
Julius Knowles Ph.D Mass General Brigham Innovation Board Member 000 0000
Martin Heidecker Ph.D Boehringer Ingelheim Venture Fund Board Member 000 0000
Roger Kitterman Mass General Brigham Innovation Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Tilos Therapeutics Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Boehringer Ingelheim Venture Fund Venture Capital Minority 000 0000 000000 0
Mass General Brigham Ventures Venture Capital Minority 000 0000 000000 0
ShangPharma Innovation Venture Capital Minority 000 0000 000000 0
To view Tilos Therapeutics’s complete investors history, request access »